Gamma Knife Market Size to Exceed USD 383.84 Bn by 2032

The Gamma Knife Market, estimated at USD 265.62 Bn in 2025, is expected to exhibit a CAGR of 5.4% and reach USD 383.84 Bn by 2032.

The industry is witnessing significant growth driven by rising demand for advanced, reliable, and cost-effective medical devices across diagnostic, therapeutic, and monitoring applications. Rapid advancements in device design, digital health integration, and adoption of minimally invasive technologies are reshaping the competitive landscape. Furthermore, supportive regulatory frameworks, increasing healthcare investments, and the growing focus on patient-centric care are expected to create new growth avenues for market players.

Increase in the number of cases of head and neck cancer, which will drive the global gamma knife market. For instance, in June 2025, according to data published in PubMed Central by the Department of Otorhinolaryngology, Azienda Sanitaria Universitaria Friuli Centrale, Tolmezzo, Italy, that head and neck (HN) cancer was the seventh most common cancer worldwide in 2025, with approximately 890,000 new cases and 450,000 deaths. A recent study from the U.S. showed that the age-adjusted incidence rates for stage IV HN cancer have significantly increased by 26.1% over the last two decades.

Global Gamma Knife Market– Impact of Coronavirus (COVID-19) Pandemic

The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China) in the last months of 2025, as "coronavirus disease 2025" or COVID-19. This virus spread quickly and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.

COVID-19 affected the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries, such as India, China, Brazil, and others, faced problems with regard to the transportation of things from one place to another.

COVID-19 had a negative impact on the global gamma knife market due to a decrease in the number of surgeries. For instance, in October 2025, according to data published in the Journal of Clinical Medicine by MDPI, overall decrease in planned surgeries was observed, which ranged across different centers from 48% to 10%, depending on the local exacerbation of the pandemic and locally imposed healthcare restrictions in normal hospital function.

Global Gamma Knife Market: Key Developments

In August 2025, Elekta, a neuroscience company, received the CE (Conformité Européenne) mark for its Elekta Esprit, a new Leksell Gamma Knife radiosurgery platform. The CE mark is the first step in enabling people with brain disease in Europe and other countries to receive treatment with this state-of-the-art system. The Leksell Gamma Knife has been designed as a gentler alternative to open surgery and conventional radiotherapy. It is indicated for the treatment of metastases, arteriovenous malformations, trigeminal neuralgia, and vestibular schwannoma.

Browse 36 Market Data Tables and 26 Figures spread through 180 Pages and in-depth TOC on “Global gamma knife Market”- Forecast to 2030, Global Gamma Knife Market, By Indication (Brain Metastasis, Arteriovenous Malformation (AVM), Trigeminal Neuralgia and Others), By Anatomy (Head, Neck and Others), By End User (Hospitals, Clinics, and Ambulatory Surgical Centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

To know the latest trends and insights prevalent in this market, click the link below:

https://www.coherentmarketinsights.com/market-insight/gamma-knife-market-408

Key Takeaways of the Global Gamma Knife Market:

• The global gamma knife market is expected to exhibit a CAGR of 5.4% during the forecast period. The merger with emerging economies offers lucrative growth opportunities for players in the global gamma knife market.
• Among indication, the Brain Metastasis segment is expected to hold a dominant position in the global gamma knife market during the forecast period, and this is attributed due to the increasing number of brain tumor surgeries. For instance, in November 2021, according to an article published in the Journal of Neurosurgery by the American Association of Neurological Surgeons Harvey Cushing Society, states that an estimated 22.6 million patients suffer from neurological disorders or injuries out of which 13.8 million required surgery.
• Among region, North America is expected to be the dominant region in the global gamma knife market, owing to the increasing number of cancer cases in the U.S. For instance, in May 2021, according to data published in a cancer journal for clinicians by the American Cancer Society, states that 1,898,160 new cancer cases and 608,570 cancer deaths are projected to occur in the U.S.
• Major players operating in the global gamma knife market are Elekta, American Radiosurgery Inc., and Masep Medical Science & Technology Development Co., Ltd., Panacea Medical Technologies Pvt. Ltd.,  Nordion (Canada) Inc.